From ‘Trouble’s Coming’ to ‘Boilermaker’, Royal Blood’s recent releases are making a phenomenal impact. After three consecutive Hottest Records courtesy of Annie Mac at Radio 1, another 50 million streams and the biggest North American airplay of their career, next Friday’s release of their third album ‘Typhoons’ is set to make the duo bigger than ever before.
Royal Blood – Mike Kerr (vocals/bass) and Ben Thatcher (drums) – now add to the amplifying momentum they’ve generated by announcing details of a 2022 UK arena tour. It includes their biggest headline show to date at London’s The O2 and represents their first full UK tour since 2017, when they sold-out three consecutive nights at London’s Alexandra Palace.
Royal Blood commented, “Playing live is the DNA and sole purpose of our band. On stage with our fans is where we belong, and we cannot wait for this tour to be a reality!”
Fans who pre-order the ‘Typhoons’ album from the band’s official store will gain exclusive access to a pre-sale for tour tickets, which opens at 9am on Wednesday, May 5th. Tickets will then go on general sale here from 9am on Friday, May 7th.
The dates are:
MARCH 2022
25th – Bournemouth, International Centre
26th – Birmingham, Utilita Arena
27th – Cardiff, Motorpoint Arena
29th – Nottingham, Motorpoint Arena
30th – London, The O2
APRIL 2022
1st – Leeds, First Direct Arena
2nd – Manchester, AO Arena
3rd – Glasgow, SSE Hydro
When Royal Blood sat down to talk about making a new album, they knew what they wanted to achieve. It involved a conscious return to their roots, back when they had made music that was influenced by Daft Punk, Justice, and Philippe Zdar of Cassius. It also called for a similar back-to-basics approach to what had made their self-titled debut album so thrilling, visceral and original. That cocktail of energy and invention resonates throughout their four recent tracks.
‘Typhoons’ heralds an exciting new era for Royal Blood, who are firmly established as one of rock’s biggest and most vital bands. Their previous two albums both went straight to #1 in the UK, in the process accumulating 2 million global sales. The duo have won the BRIT Award for Best British Group, two NME Awards and a Kerrang! Award. Their debut album was also nominated for the Mercury Prize.
